Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

Monday’s Trading Day
129.14 +0.355 / +0.28%
As of Mar 30
Day’s Change
Tuesday’s Pre-Market   Switch to standard view »
128.00 -1.13 / -0.88%
 
Volume: 10.8K

Today’s Trading

Previous close128.78
Today’s open131.33
Day’s range-- - --
Volume2,828,641
Average volume (3 months)1,551,822
Market cap$20.5B
Dividend yield--
Data as of 03/30/2015

Growth & Valuation

Earnings growth (last year)+28.13%
Earnings growth (this year)-146.57%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+36.76%
P/E ratioNM
Price/Sales17.64
Price/Book12.57

Competitors

 Today’s
change
Today’s
% change
PCYCPharmacyclics Inc-0.13-0.05%
ZTSZoetis Inc+0.70+1.51%
PRGOPerrigo Company PLC+2.29+1.38%
INCYIncyte Corp-0.17-0.18%
Data as of 03/30/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)-$0.51
Annual revenue (last year)$750.0M
Annual profit (last year)-$134.0M
Net profit margin-17.86%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Jean-Jacques Bienaimé
Chief Financial Officer &
Executive Vice President
Daniel K. Spiegelman
Corporate headquarters
San Rafael, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account